DOE PAGES title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Catalytic site inhibition of insulin-degrading enzyme by a small molecule induces glucose intolerance in mice

Abstract

Insulin-degrading enzyme (IDE) is a protease that cleaves insulin and other bioactive peptides such as amyloid-β. Knockout and genetic studies have linked IDE to Alzheimer’s disease and type-2 diabetes. As the major insulin-degrading protease, IDE is a candidate drug target in diabetes. Here we have used kinetic target-guided synthesis to design the first catalytic site inhibitor of IDE suitable for in vivo studies (BDM44768). Crystallographic and small angle X-ray scattering analyses show that it locks IDE in a closed conformation. Among a panel of metalloproteases, BDM44768 selectively inhibits IDE. Acute treatment of mice with BDM44768 increases insulin signalling and surprisingly impairs glucose tolerance in an IDE-dependent manner. These results confirm that IDE is involved in pathways that modulate short-term glucose homeostasis, but casts doubt on the general usefulness of the inhibition of IDE catalytic activity to treat diabetes.

Authors:
 [1];  [2];  [1];  [3];  [4];  [1];  [1];  [1];  [1];  [1];  [1];  [1];  [1];  [5];  [1];  [6];  [7];  [1];  [8];  [9] more »;  [9];  [1];  [1];  [1];  [8];  [1];  [3];  [4];  [6];  [1] « less
  1. Institut Pasteur de Lille and Universite de Lille and Institut National de la Sante et de la Recherche Medicale and Institut Federatif de Recherche (France)
  2. Institut Pasteur de Lille and Universite de Lille and Institut National de la Sante et de la Recherche Medicale (France)
  3. Univ. of Chicago, IL (United States)
  4. Universite Paris Descartes (France)
  5. Institut Pasteur de Lille and Universite de Lille Institut National de la Sante et de la Recherche Medicale (France)
  6. Institut Pasteur de Lille and Universite de Lille Institut National de la Sante et de la Recherche Medicale (France)
  7. Institut Pasteur de Lille and Universite de Lille Institut National de la Sante et de la Recherche Medicale(France)
  8. Universite de Lille (France)
  9. Universite d'Artois, Lens (France)
Publication Date:
Research Org.:
Argonne National Lab. (ANL), Argonne, IL (United States)
Sponsoring Org.:
USDOE Office of Science (SC), Biological and Environmental Research (BER)
OSTI Identifier:
1218714
Grant/Contract Number:  
AC02-06CH11357
Resource Type:
Accepted Manuscript
Journal Name:
Nature Communications
Additional Journal Information:
Journal Volume: 6; Journal ID: ISSN 2041-1723
Publisher:
Nature Publishing Group
Country of Publication:
United States
Language:
English
Subject:
59 BASIC BIOLOGICAL SCIENCES; Biological sciences; medical research

Citation Formats

Deprez-Poulain, Rebecca, Hennuyer, Nathalie, Bosc, Damien, Liang, Wenguang G., Enée, Emmanuelle, Marechal, Xavier, Charton, Julie, Totobenazara, Jane, Berte, Gonzague, Jahklal, Jouda, Verdelet, Tristan, Dumont, Julie, Dassonneville, Sandrine, Woitrain, Eloise, Gauriot, Marion, Paquet, Charlotte, Duplan, Isabelle, Hermant, Paul, Cantrelle, François- Xavier, Sevin, Emmanuel, Culot, Maxime, Landry, Valerie, Herledan, Adrien, Piveteau, Catherine, Lippens, Guy, Leroux, Florence, Tang, Wei-Jen, van Endert, Peter, Staels, Bart, and Deprez, Benoit. Catalytic site inhibition of insulin-degrading enzyme by a small molecule induces glucose intolerance in mice. United States: N. p., 2015. Web. doi:10.1038/ncomms9250.
Deprez-Poulain, Rebecca, Hennuyer, Nathalie, Bosc, Damien, Liang, Wenguang G., Enée, Emmanuelle, Marechal, Xavier, Charton, Julie, Totobenazara, Jane, Berte, Gonzague, Jahklal, Jouda, Verdelet, Tristan, Dumont, Julie, Dassonneville, Sandrine, Woitrain, Eloise, Gauriot, Marion, Paquet, Charlotte, Duplan, Isabelle, Hermant, Paul, Cantrelle, François- Xavier, Sevin, Emmanuel, Culot, Maxime, Landry, Valerie, Herledan, Adrien, Piveteau, Catherine, Lippens, Guy, Leroux, Florence, Tang, Wei-Jen, van Endert, Peter, Staels, Bart, & Deprez, Benoit. Catalytic site inhibition of insulin-degrading enzyme by a small molecule induces glucose intolerance in mice. United States. https://doi.org/10.1038/ncomms9250
Deprez-Poulain, Rebecca, Hennuyer, Nathalie, Bosc, Damien, Liang, Wenguang G., Enée, Emmanuelle, Marechal, Xavier, Charton, Julie, Totobenazara, Jane, Berte, Gonzague, Jahklal, Jouda, Verdelet, Tristan, Dumont, Julie, Dassonneville, Sandrine, Woitrain, Eloise, Gauriot, Marion, Paquet, Charlotte, Duplan, Isabelle, Hermant, Paul, Cantrelle, François- Xavier, Sevin, Emmanuel, Culot, Maxime, Landry, Valerie, Herledan, Adrien, Piveteau, Catherine, Lippens, Guy, Leroux, Florence, Tang, Wei-Jen, van Endert, Peter, Staels, Bart, and Deprez, Benoit. Wed . "Catalytic site inhibition of insulin-degrading enzyme by a small molecule induces glucose intolerance in mice". United States. https://doi.org/10.1038/ncomms9250. https://www.osti.gov/servlets/purl/1218714.
@article{osti_1218714,
title = {Catalytic site inhibition of insulin-degrading enzyme by a small molecule induces glucose intolerance in mice},
author = {Deprez-Poulain, Rebecca and Hennuyer, Nathalie and Bosc, Damien and Liang, Wenguang G. and Enée, Emmanuelle and Marechal, Xavier and Charton, Julie and Totobenazara, Jane and Berte, Gonzague and Jahklal, Jouda and Verdelet, Tristan and Dumont, Julie and Dassonneville, Sandrine and Woitrain, Eloise and Gauriot, Marion and Paquet, Charlotte and Duplan, Isabelle and Hermant, Paul and Cantrelle, François- Xavier and Sevin, Emmanuel and Culot, Maxime and Landry, Valerie and Herledan, Adrien and Piveteau, Catherine and Lippens, Guy and Leroux, Florence and Tang, Wei-Jen and van Endert, Peter and Staels, Bart and Deprez, Benoit},
abstractNote = {Insulin-degrading enzyme (IDE) is a protease that cleaves insulin and other bioactive peptides such as amyloid-β. Knockout and genetic studies have linked IDE to Alzheimer’s disease and type-2 diabetes. As the major insulin-degrading protease, IDE is a candidate drug target in diabetes. Here we have used kinetic target-guided synthesis to design the first catalytic site inhibitor of IDE suitable for in vivo studies (BDM44768). Crystallographic and small angle X-ray scattering analyses show that it locks IDE in a closed conformation. Among a panel of metalloproteases, BDM44768 selectively inhibits IDE. Acute treatment of mice with BDM44768 increases insulin signalling and surprisingly impairs glucose tolerance in an IDE-dependent manner. These results confirm that IDE is involved in pathways that modulate short-term glucose homeostasis, but casts doubt on the general usefulness of the inhibition of IDE catalytic activity to treat diabetes.},
doi = {10.1038/ncomms9250},
journal = {Nature Communications},
number = ,
volume = 6,
place = {United States},
year = {Wed Sep 23 00:00:00 EDT 2015},
month = {Wed Sep 23 00:00:00 EDT 2015}
}

Journal Article:
Free Publicly Available Full Text
Publisher's Version of Record

Citation Metrics:
Cited by: 58 works
Citation information provided by
Web of Science

Save / Share:

Works referenced in this record:

Insulin-Degrading Enzyme: Structure-Function Relationship and its Possible Roles in Health and Disease
journal, November 2009


The insulysin (insulin degrading enzyme) enigma
journal, September 2006


Alzheimer's β-amyloid peptide specifically interacts with and is degraded by insulin degrading enzyme
journal, May 1994


Molecular Basis for the Recognition and Cleavages of IGF-II, TGF-α, and Amylin by Human Insulin-Degrading Enzyme
journal, January 2010


Endosomal Proteolysis of Glucagon at Neutral pH Generates the Bioactive Degradation Product Miniglucagon-(19–29)
journal, December 2003

  • Authier, François; Cameron, Pamela H.; Merlen, Clémence
  • Endocrinology, Vol. 144, Issue 12
  • DOI: 10.1210/en.2003-0543

Somatostatin: A Novel Substrate and a Modulator of Insulin-Degrading Enzyme Activity
journal, February 2009

  • Ciaccio, Chiara; Tundo, Grazia R.; Grasso, Giuseppe
  • Journal of Molecular Biology, Vol. 385, Issue 5
  • DOI: 10.1016/j.jmb.2008.11.025

Amyloidogenic determinant as a substrate recognition motif of insulin-degrading enzyme
journal, May 1998


Structures of human insulin-degrading enzyme reveal a new substrate recognition mechanism
journal, October 2006

  • Shen, Yuequan; Joachimiak, Andrzej; Rich Rosner, Marsha
  • Nature, Vol. 443, Issue 7113
  • DOI: 10.1038/nature05143

Amyloid β-degrading cryptidases: insulin degrading enzyme, presequence peptidase, and neprilysin
journal, May 2008

  • Malito, E.; Hulse, R. E.; Tang, W. -J.
  • Cellular and Molecular Life Sciences, Vol. 65, Issue 16
  • DOI: 10.1007/s00018-008-8112-4

Functional Relevance of a Novel SlyX Motif in Non-conventional Secretion of Insulin-degrading Enzyme
journal, May 2011

  • Glebov, Konstantin; Schütze, Sebastian; Walter, Jochen
  • Journal of Biological Chemistry, Vol. 286, Issue 26
  • DOI: 10.1074/jbc.C110.217893

Insulin inhibition of the proteasome is dependent on degradation of insulin by insulin-degrading enzyme
journal, June 2003

  • Bennett, Rg; Fawcett, J.; Kruer, Mc
  • Journal of Endocrinology, Vol. 177, Issue 3
  • DOI: 10.1677/joe.0.1770399

Stem cell antigen-1 localizes to lipid microdomains and associates with insulin degrading enzyme in skeletal myoblasts
journal, October 2008

  • Epting, Conrad L.; King, Frank W.; Pedersen, Anissa
  • Journal of Cellular Physiology, Vol. 217, Issue 1
  • DOI: 10.1002/jcp.21500

Deletion of the Fission Yeast Homologue of Human Insulinase Reveals a TORC1-Dependent Pathway Mediating Resistance to Proteotoxic Stress
journal, June 2013


Proteolytically Inactive Insulin-Degrading Enzyme Inhibits Amyloid Formation Yielding Non-Neurotoxic Aβ Peptide Aggregates
journal, April 2013


Effect of Insulinase-Inhibitor on Hypoglycemic Action of Insulin
journal, September 1955


Genetic analysis of non-insulin dependent diabetes mellitus in the GK rat
journal, January 1996

  • Galli, Joakim; Li, Luo-Sheng; Glaser, Anna
  • Nature Genetics, Vol. 12, Issue 1
  • DOI: 10.1038/ng0196-31

Insulin-degrading enzyme identified as a candidate diabetes susceptibility gene in GK rats
journal, September 2000


Partial Loss-of-Function Mutations in Insulin-Degrading Enzyme that Induce Diabetes also Impair Degradation of Amyloid β-Protein
journal, April 2004

  • Farris, Wesley; Mansourian, Stefan; Leissring, Malcolm A.
  • The American Journal of Pathology, Vol. 164, Issue 4
  • DOI: 10.1016/S0002-9440(10)63229-4

Insulin-degrading enzyme regulates the levels of insulin, amyloid  -protein, and the  -amyloid precursor protein intracellular domain in vivo
journal, March 2003

  • Farris, W.; Mansourian, S.; Chang, Y.
  • Proceedings of the National Academy of Sciences, Vol. 100, Issue 7
  • DOI: 10.1073/pnas.0230450100

Deletion of Insulin-Degrading Enzyme Elicits Antipodal, Age-Dependent Effects on Glucose and Insulin Tolerance
journal, June 2011


Designed Inhibitors of Insulin-Degrading Enzyme Regulate the Catabolism and Activity of Insulin
journal, May 2010


Optimization of Peptide Hydroxamate Inhibitors of Insulin-Degrading Enzyme Reveals Marked Substrate-Selectivity
journal, March 2013

  • Abdul-Hay, Samer O.; Lane, Amy L.; Caulfield, Thomas R.
  • Journal of Medicinal Chemistry, Vol. 56, Issue 6
  • DOI: 10.1021/jm301280p

Anti-diabetic activity of insulin-degrading enzyme inhibitors mediated by multiple hormones
journal, May 2014

  • Maianti, Juan Pablo; McFedries, Amanda; Foda, Zachariah H.
  • Nature, Vol. 511, Issue 7507
  • DOI: 10.1038/nature13297

Kinetic target-guided synthesis
journal, January 2010

  • Hu, Xiangdong; Manetsch, Roman
  • Chemical Society Reviews, Vol. 39, Issue 4
  • DOI: 10.1039/b904092g

In Situ Click Chemistry:  Enzyme Inhibitors Made to Their Own Specifications
journal, October 2004

  • Manetsch, Roman; Krasiński, Antoni; Radić, Zoran
  • Journal of the American Chemical Society, Vol. 126, Issue 40
  • DOI: 10.1021/ja046382g

In Situ Click Chemistry: Enzyme-Generated Inhibitors of Carbonic Anhydrase II
journal, December 2004

  • Mocharla, Vani P.; Colasson, Benoit; Lee, Lac V.
  • Angewandte Chemie International Edition, Vol. 44, Issue 1
  • DOI: 10.1002/anie.200461580

Inhibitors of HIV-1 Protease by Using In Situ Click Chemistry
journal, February 2006

  • Whiting, Matthew; Muldoon, John; Lin, Ying-Chuan
  • Angewandte Chemie International Edition, Vol. 45, Issue 9
  • DOI: 10.1002/anie.200502161

Chitinase inhibitors: extraction of the active framework from natural argifin and use of in situ click chemistry
journal, March 2009

  • Hirose, Tomoyasu; Sunazuka, Toshiaki; Sugawara, Akihiro
  • The Journal of Antibiotics, Vol. 62, Issue 5
  • DOI: 10.1038/ja.2009.28

Exploring Drug Target Flexibility Using in Situ Click Chemistry: Application to a Mycobacterial Transcriptional Regulator
journal, August 2010

  • Willand, Nicolas; Desroses, Matthieu; Toto, Patrick
  • ACS Chemical Biology, Vol. 5, Issue 11
  • DOI: 10.1021/cb100177g

Imidazole-derived 2-[N-carbamoylmethyl-alkylamino]acetic acids, substrate-dependent modulators of insulin-degrading enzyme in amyloid-β hydrolysis
journal, May 2014


Absolute Potassium Cation Affinities (PCAs) in the Gas Phase
journal, July 2003

  • Lau, Justin Kai-Chi; Wong, Carrie Hoi Shan; Ng, Po Shan
  • Chemistry - A European Journal, Vol. 9, Issue 14
  • DOI: 10.1002/chem.200204678

1,2,5-, 1,3,4- and 1,2,4-Oxadiazoles: A theoretical study of electric dipole moments
journal, January 1968

  • Brown, R. D.; Coller, B. A. W.; Kent, J. E.
  • Theoretica Chimica Acta, Vol. 10, Issue 5
  • DOI: 10.1007/BF00528774

Conformational states and recognition of amyloidogenic peptides of human insulin-degrading enzyme
journal, August 2013

  • McCord, Lauren A.; Liang, Wenguang G.; Dowdell, Evan
  • Proceedings of the National Academy of Sciences, Vol. 110, Issue 34
  • DOI: 10.1073/pnas.1304575110

Hydroxamates: Relationships between Structure and Plasma Stability
journal, November 2009

  • Flipo, Marion; Charton, Julie; Hocine, Akila
  • Journal of Medicinal Chemistry, Vol. 52, Issue 21
  • DOI: 10.1021/jm900648x

Insulin-degrading Enzyme Regulates Extracellular Levels of Amyloid β-Protein by Degradation
journal, December 1998

  • Qiu, Wei Qiao; Walsh, Dominic M.; Ye, Zhen
  • Journal of Biological Chemistry, Vol. 273, Issue 49
  • DOI: 10.1074/jbc.273.49.32730

Insulin-degrading Enzyme Rapidly Removes the β-Amyloid Precursor Protein Intracellular Domain (AICD)
journal, January 2002

  • Edbauer, Dieter; Willem, Michael; Lammich, Sven
  • Journal of Biological Chemistry, Vol. 277, Issue 16
  • DOI: 10.1074/jbc.M111571200

Molecular Basis of Catalytic Chamber-assisted Unfolding and Cleavage of Human Insulin by Human Insulin-degrading Enzyme
journal, March 2009

  • Manolopoulou, Marika; Guo, Qing; Malito, Enrico
  • Journal of Biological Chemistry, Vol. 284, Issue 21
  • DOI: 10.1074/jbc.M900068200

[20] Processing of X-ray diffraction data collected in oscillation mode
book, January 1997


The CCP 4 molecular-graphics project
journal, October 2002

  • Potterton, Elizabeth; McNicholas, Stuart; Krissinel, Eugene
  • Acta Crystallographica Section D Biological Crystallography, Vol. 58, Issue 11
  • DOI: 10.1107/S0907444902015391

Coot model-building tools for molecular graphics
journal, November 2004

  • Emsley, Paul; Cowtan, Kevin
  • Acta Crystallographica Section D Biological Crystallography, Vol. 60, Issue 12, p. 2126-2132
  • DOI: 10.1107/S0907444904019158

Determination of the regularization parameter in indirect-transform methods using perceptual criteria
journal, August 1992


CRYSOL – a Program to Evaluate X-ray Solution Scattering of Biological Macromolecules from Atomic Coordinates
journal, December 1995

  • Svergun, D.; Barberato, C.; Koch, M. H. J.
  • Journal of Applied Crystallography, Vol. 28, Issue 6
  • DOI: 10.1107/S0021889895007047

Works referencing / citing this record:

Preparation of Selenoinsulin as a Long-Lasting Insulin Analogue
journal, April 2017

  • Arai, Kenta; Takei, Toshiki; Okumura, Masaki
  • Angewandte Chemie International Edition, Vol. 56, Issue 20
  • DOI: 10.1002/anie.201701654

Efforts towards an On‐Target Version of the Groebke–Blackburn–Bienaymé (GBB) Reaction for Discovery of Druglike Urokinase (uPA) Inhibitors
journal, August 2019

  • Gladysz, Rafaela; Vrijdag, Johannes; Van Rompaey, Dries
  • Chemistry – A European Journal, Vol. 25, Issue 53
  • DOI: 10.1002/chem.201901917

Bridging Type 2 Diabetes and Alzheimer's Disease: Assembling the Puzzle Pieces in the Quest for the Molecules With Therapeutic and Preventive Potential
journal, April 2017

  • de Matos, Ana Marta; de Macedo, Maria Paula; Rauter, Amélia Pilar
  • Medicinal Research Reviews, Vol. 38, Issue 1
  • DOI: 10.1002/med.21440

The insulin-degrading enzyme is an allosteric modulator of the 20S proteasome and a potential competitor of the 19S
journal, March 2018

  • Sbardella, Diego; Tundo, Grazia R.; Coletta, Andrea
  • Cellular and Molecular Life Sciences, Vol. 75, Issue 18
  • DOI: 10.1007/s00018-018-2807-y

Substrate-selective inhibitors that reprogram the activity of insulin-degrading enzyme
journal, May 2019

  • Maianti, Juan Pablo; Tan, Grace A.; Vetere, Amedeo
  • Nature Chemical Biology, Vol. 15, Issue 6
  • DOI: 10.1038/s41589-019-0271-0

Multiple functions of insulin-degrading enzyme: a metabolic crosslight?
journal, June 2017

  • Tundo, Grazia R.; Sbardella, Diego; Ciaccio, Chiara
  • Critical Reviews in Biochemistry and Molecular Biology, Vol. 52, Issue 5
  • DOI: 10.1080/10409238.2017.1337707

Pancreatic β-cell-specific deletion of insulin-degrading enzyme leads to dysregulated insulin secretion and β-cell functional immaturity
journal, November 2019

  • Fernández-Díaz, Cristina M.; Merino, Beatriz; López-Acosta, José F.
  • American Journal of Physiology-Endocrinology and Metabolism, Vol. 317, Issue 5
  • DOI: 10.1152/ajpendo.00040.2019

Ablation of amyloid precursor protein increases insulin-degrading enzyme levels and activity in brain and peripheral tissues
journal, January 2019

  • Kulas, Joshua A.; Franklin, Whitney F.; Smith, Nicholas A.
  • American Journal of Physiology-Endocrinology and Metabolism, Vol. 316, Issue 1
  • DOI: 10.1152/ajpendo.00279.2018

Drug Target Engagement Using Coupled Cellular Thermal Shift Assay—Acoustic Reverse-Phase Protein Array
journal, December 2019

  • Herledan, Adrien; Andres, Marine; Lejeune-Dodge, Aurore
  • SLAS DISCOVERY: Advancing the Science of Drug Discovery, Vol. 25, Issue 2
  • DOI: 10.1177/2472555219897256

Novel C15 Triene Triazole, D-A Derivatives Anti-HepG2, and as HDAC2 Inhibitors: A Synergy Study
journal, October 2018

  • Qi, Zhiwen; Wang, Chengzhang; Jiang, Jianxin
  • International Journal of Molecular Sciences, Vol. 19, Issue 10
  • DOI: 10.3390/ijms19103184

Ensemble cryoEM elucidates the mechanism of insulin capture and degradation by human insulin degrading enzyme
text, January 2018

  • Zhang, Zhening; Liang, Wenguang G.; Bailey, Lucas J.
  • Columbia University
  • DOI: 10.7916/d8r79xv2